Table 3.

Peptide-modified nanoparticles.

Name	Ligand	Carrier	Therapeutics	Cancer Type	Ref
CGKRK-NP	CGKRK	PCL	PTX	glioma	[53]
PC-NP-PTX	CGKRK, Pep-1 (IL-13Rα2)	PLGA	PTX	glioma	[54]
GX1-DGC-DCT	GX1	chitosan	DCT	gastric cancer	[56]
P-(F56)-DOX	F56	HPMA	DOX	melanoma, lung cancer, colon cancer	[58]
F56-PTX-NP	F56	PLA	PTX	breast cancer	[59]
Esbp-HA-PTX	Esbp	micelle	PTX	breast cancer	[60]
ASSHN-Lip	ASSHNGC	LP	DOX	melanoma, colon	[61]